F9 and hemophilia B: In this study, we explored in mice the efficacy of ExSpeU1 toward exon-skipping mutations leading to Hemophilia B (HB) that is a rare X-linked hemorrhagic disorder (1/35,000 males) associated with reduced levels of factor IX (FIX), a key coagulation protein of liver origin.30